Close

PILULKA LÉKÁRNY

Period:
 - 
Change in selected period :
Source:
Turnover in CZK

Intraday data


Date & Time
23.05.2025 | 10:05:56
Last
CZK 207.00
Change
0,98 %
Change Abs.
CZK 2.00
ISIN
CZ0009009874
C
MPQ
Continuous Trading
IPO price
CZK 424.00
Note

Information and documents related to initial subscriptions and public offerings can be found in the Subscriptions section.

Basic Information

Market MTF
Market Segment START Market
Type Of Security Shares
Ticker Bloomberg PINK CP Equity
Ticker Reuters PINK.PR
Ticker Xetra® PINK
Shares Included 2 706 678 pcs
Market Capitalization CZK 560.28 mio.

Indicators

YTD Performance 92,56 %

Included in the following indices

Name Last Change
PX-START 1,347.25 -0,45 %

Trading

Trading Procedure Continuous Trading
Trading Unit Pieces
Trading Hours 08:50 - 16:25
Time Of Opening Auction 8:50
Time Of Closing Auction 16:10
Trade At Close 16:15
Trading Currency CZK
First Day of Trading 26. 10. 2020
  • Calculated by Vienna Stock Exchange (Wiener Börse AG)

Market Depth

Prices 15 minutes delayed | Closing data from the last trading day during off-trading hours | Market indicator shows analysts' consensus provided by Refinitiv
Bid
Ask
Number of Orders Quantity Price Price Quantity Number of Orders
3 570 pcs CZK 201.00 CZK 206.00 60 pcs 1
2 1 988 pcs CZK 200.00 CZK 207.00 218 pcs 1
1 120 pcs CZK 199.00 CZK 208.00 1 954 pcs 2
1 60 pcs CZK 198.00 CZK 210.00 45 pcs 2
1 50 pcs CZK 190.00 CZK 214.00 180 pcs 2

Time Axis

Start End
Bid/Ask 201.00/206.00
Bid Size/Ask Size 570.00/60.00
Open CZK 201.00
High CZK 207.00
Low CZK 201.00
Last Close CZK 205.00
Last Volume 234
Total Turnover in Pcs 1 062 pcs
Total Turnover in CZK CZK 216,006.00
Number of Trades 10
Year High CZK 260.00
Year Low CZK 84.00
From
To
Search
Change in selected period
Turnover in selected period |
Company
Pilulka Lékárny a.s.
Address
Českomoravská 2408/1a, 190 00, Praha
Website Company Profile
Pilulka Lékárny is a technology company operating in the Czech Republic and Slovakia. It operates brick-and-mortar pharmacies and an e-shop, which, among other things, also focuses on the sale of medicines, sports nutrition, food supplements or children's supplies.
last update: 25.04.2025 18:10
DISCLAIMER: Financial data are provided to Prague Stock Exchange, a.s. by individual issuers who are responsible for their accuracy. Data are taken from the issuer´s annual reports which are published in the company profile&reports section, and also on the issuer´s website: https://www.pilulka.cz/pro-investory. Prague Stock Exchange, a.s. does not provide any guarantees for the published data, is not responsible for any typing errors or omissions, or for any decisions taken on such data. More information: https://www.pse.cz/en/legal-information.


XLSX export
last update: 23.05.2025 12:10
last update: 23.05.2025 12:10

NOTES:
Preliminary financial results and the annual financial report are related to the previous financial year. The calendar includes the date of the general meeting where the financial statements for the previous financial year are approved.

DISCLAIMER:
The dates provided are supplied to the Prague Stock Exchange by individual issuers who are responsible for their accuracy. The Prague Stock Exchange provides no guarantees for the data, is not responsible for any errors or typos, or for any decisions made based on this data. For more information, please visit: https://www.pse.cz/en/legal-information. Dates marked with * are not supplied by the issuer, they are deadlines set by the exchange rules. Dates may change throughout the year.

PILULKA LÉKÁRNY: established to consolidate a fragmented business

In the late 90s the Kasa brothers were the pioneers of Czech e-commerce and built one of the largest e-shops back then. Later, they sensed the opportunity in a lucrative but conservative and fragmented healthcare sector, and Pilulka.cz was born.

SUCCESSFULLY LISTED
View full story

Disclaimer: The text on this website does not constitute an offer or invitation to sell or buy investment instruments or a recommendation to trade investment instruments. Investors should consult their legal, financial and other professional advisors before making investment decisions. Investors should also read the contents of the prospectus and other documents containing information about a particular investment instrument and its issuer before making an investment decision in order to fully understand the potential risks associated with a decision to invest in that investment instrument. The prospectus of a security shall always be available in electronic form on the issuer's website before the commencement of the public offer or before the admission of the security to trading on a regulated market.